DexCom (DXCM) Tops Q3 EPS by 16c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.96 -0.22%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Interest expense: -200K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.50, $0.16 better than the analyst estimate of $0.34. Revenue for the quarter came in at $975 million versus the consensus estimate of $939.19 million.
GUIDANCE:
DexCom sees FY2023 revenue of $3.575-3.6 million, versus the consensus of $3.539 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Bath & Body Works, Inc. (BBWI) Tops Q2 EPS by 38c, Offers FY27 EPS Guidance
- CrowdStrike shares jump on earnings beat, raised outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
